Through the combination of software analysis, physical and chemical testing, immunoassay, accelerated tests, PK study (the PK detection platform has passed the blood sample analysis capability verification by NIFDC in 2019), developability, etc., candidate molecules are evaluated in multiple aspects, and finally, the lead molecules met the druggability requirements are picked.